These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Capecitabine-induced subacute cutaneous lupus: a case report]. Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062 [TBL] [Abstract][Full Text] [Related]
8. Oral ulcers and sarcoid-like reaction in lymph nodes after cemiplimab therapy for locally advanced cutaneous squamous cell carcinoma: a case report. Ferreira MH; Bezinelli LM; Eduardo FP; Gobbi MF; Corrêa L; Schvartsman G Einstein (Sao Paulo); 2022; 20():eRC6367. PubMed ID: 35303053 [TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors-related subacute cutaneous lupus erythematosus: Clinical characteristics, management, and outcome. Deng Z; Guo A; Wu C; Wang C J Cosmet Dermatol; 2022 Dec; 21(12):7202-7208. PubMed ID: 36214602 [TBL] [Abstract][Full Text] [Related]
10. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma. Baggi A; Quaglino P; Rubatto M; Depenni R; Guida M; Ascierto PA; Trojaniello C; Queirolo P; Saponara M; Peris K; Spagnolo F; Bianchi L; De Galitiis F; Potenza MC; Proietti I; Marconcini R; Botticelli A; Barbieri V; Licitra L; Alfieri S; Ficorella C; Cortellini A; Fargnoli MC; Troiani T; Tondulli L; Bossi P Eur J Cancer; 2021 Nov; 157():250-258. PubMed ID: 34536948 [TBL] [Abstract][Full Text] [Related]
11. [Subacute cutaneous lupus erythematosus induced by terbinafine]. Amitay-Layish I; Feuerman H; David M Harefuah; 2006 Jul; 145(7):480-2, 552. PubMed ID: 16900733 [TBL] [Abstract][Full Text] [Related]
12. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. Chlebus E; Wolska H; Blaszczyk M; Jablonska S J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021 [TBL] [Abstract][Full Text] [Related]
13. Cemiplimab-induced cytokine-release syndrome: second case reported and review of the literature. Lhuillier M; Brière M; Artifoni M; Chapal M; Peuvrel L; Saint-Jean M Immunotherapy; 2023 Mar; 15(4):229-234. PubMed ID: 36789558 [TBL] [Abstract][Full Text] [Related]
14. Leflunomide in subacute cutaneous lupus erythematosus - two sides of a coin. Suess A; Sticherling M Int J Dermatol; 2008 Jan; 47(1):83-6. PubMed ID: 18173611 [TBL] [Abstract][Full Text] [Related]
16. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma. Migden MR; Rischin D; Schmults CD; Guminski A; Hauschild A; Lewis KD; Chung CH; Hernandez-Aya L; Lim AM; Chang ALS; Rabinowits G; Thai AA; Dunn LA; Hughes BGM; Khushalani NI; Modi B; Schadendorf D; Gao B; Seebach F; Li S; Li J; Mathias M; Booth J; Mohan K; Stankevich E; Babiker HM; Brana I; Gil-Martin M; Homsi J; Johnson ML; Moreno V; Niu J; Owonikoko TK; Papadopoulos KP; Yancopoulos GD; Lowy I; Fury MG N Engl J Med; 2018 Jul; 379(4):341-351. PubMed ID: 29863979 [TBL] [Abstract][Full Text] [Related]
17. A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment. Andric M; Dixit S; Robaei D; Watchorn R; Verma N Indian J Ophthalmol; 2013 Dec; 61(12):752-4. PubMed ID: 24212210 [TBL] [Abstract][Full Text] [Related]